Share Name Share Symbol Market Type Share ISIN Share Description
Tekcapital Plc LSE:TEK London Ordinary Share GB00BKXGY798 ORD �0.004
  Price Change % Change Share Price Shares Traded Last Trade
  -0.25 -1.69% 14.50 481,866 13:36:30
Bid Price Offer Price High Price Low Price Open Price
13.50 15.50 14.75 14.40 14.75
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Technology Hardware & Equipment 5.36 3.57 8.08 2.0 13
Last Trade Time Trade Type Trade Size Trade Price Currency
15:43:50 O 3,920 15.10 GBX

Tekcapital (TEK) Latest News

More Tekcapital News
Tekcapital Investors    Tekcapital Takeover Rumours

Tekcapital (TEK) Discussions and Chat

Tekcapital (TEK) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
2021-02-26 15:43:5115.103,920591.92O
2021-02-26 15:28:4113.7039554.12O
2021-02-26 15:25:5614.50100,00014,500.00O
2021-02-26 13:36:2214.187,2221,024.15O
2021-02-26 13:16:3915.2016,4072,493.86O
View all Tekcapital trades in real-time

Tekcapital (TEK) Top Chat Posts

Tekcapital Daily Update: Tekcapital Plc is listed in the Technology Hardware & Equipment sector of the London Stock Exchange with ticker TEK. The last closing price for Tekcapital was 14.75p.
Tekcapital Plc has a 4 week average price of 14p and a 12 week average price of 13.25p.
The 1 year high share price is 23p while the 1 year low share price is currently 3.75p.
There are currently 92,828,042 shares in issue and the average daily traded volume is 254,634 shares. The market capitalisation of Tekcapital Plc is £13,460,066.09.
faz: Most BB posters are holders, like all BBs. However the company's investments all seem to progressing nicely to profit which should re-rate TEK over the next twelve months. I have held and added over the last 10 months .
cleverinvester: Aspers : such a jinx .He sells out of CNA losses of £160k and now CNA is flying.Watch out if Aspers announced he sells up TEK , That's the time to buy in.
cleverinvester: Nursing your losses today Aspers?Tek/IAG/SAGA/CNAWhat a jinx you are .Ah ha ha ah
mick1909: It has fallen 1p since your prediction sunday close of play friday 18p current share price 17p but you stated monday was going lower it rised monday and tuesday then it became overbought RSI 82 The RSI is now 58 so i see it consolating around this price ready for the next leg up 25p surpassing 52 week high
camkite: The regenerative shock absorbers has to be the best prospect TEK have. Crazy upside on deals being signed with electric car companies. If a company with just this technology was listed on Lse with NDA’s with two listed car companies, it would be valued at multiples of this share price. £1 sooner than we think.
smackeraim: Tekcapital plc, (AIM: TEK) the UK intellectual property investment group focused on creating marketplace value from investing in university technology, announces that its portfolio company Belluscura plc has submitted the X-PLO(2) R(TM) portable oxygen concentrator for 510(k) clearance with the U.S. FDA
camo1997: Been watching this for a while, and like the main business model. Looking over the fundamentals looks promising, BV of near 30p and future value in 2yrs at this current rate of 54p ish. From their recent report, debt ratio very very low and other bits in the balance sheet look good. Looks like it has been diluted though over the years, however can't quite see why the share price not higher. Also can't see its too correlated to the main market, so may be good during these times. Management looks good as well, most of which went to Oxford (not sure if that's a good thing or not lol). Worth a punt, any thoughts? Will get to know you guys lol, may be here a bit more. Few main bits Date 2020 Debt Ratio 0.009 Current Ratio 8.69 Cash ratio 4.33 Date 2020 PE 4.04 EPS 0.03 EPS Growth -59% Mean Return 12.62% Volatility 37.29% Skew 0.772 Kurtosis -0.240 Beta (FTSE 100) 0.385 Correlation (FTSE 100) 0.059 R^2 (FTSE 100) 0.004 Date 2020 Book Value Per Share 0.297 Share Price 0.105 Price to Book 0.353 Book Value Growth 16%
under the radar: OT ... Heads up (BOR) Borders and Southern :- 1)465m barrels of condensate (light sweet crude) 2)Own 100% of all acreage 3)Darwin (discovery) costs are under $35 a barrel 4)474m shares in issue 5)£3m mkt cap = nothing at all priced in and priced to fail 6)Bod own over 10% of shares 7)Rkh sea lion will get sanctioned next year which will do wonders for BOR 8)Bottomed - no sellers left as all flushed out 9)Bullish divergence on chart with bullish white candles being formed and it’s totally oversold on stochastic rsi 10)Enough money to last until April 2023 11)Update due in next 2 weeks The Market was over pessimistic and now a correction is due (it’s JUST starting now) Share price 0.7525p - it won’t be under 1p for long imho Put it on your watch list at the very least and see for yourself what happens I wish you luck whatever you decide! ATB
scoble2: patience is the virtue. It has a market capitalisation of £9m, with approximately 88m shares in issue. Over the last year, TekCapital share price has been traded in a range of 17.3, hitting a high of 21, and a low of 3.7.
someuwin: 26 June 2019 Tekcapital Plc ("Tekcapital", the "Company" or "the Group") Portfolio Company Update: Belluscura plc On track to likely receive FDA clearance later this year Tekcapital Plc (AIM: TEK), the UK intellectual property (IP) investment group focused on creating marketplace value from investing in university technology, is pleased to announce that its portfolio company Belluscura plc has received commitments for GBP725,000 of additional funding at 15p/share and is on track to receive FDA clearance later this year followed by commercial launch in H1 2020. The Product Belluscura has developed a patented portable oxygen concentrator called the X-PLOR, that can deliver 96% pure oxygen to patients 24/7. According to the Company(1) , the X-PLOR is designed to replace metal oxygen tanks and heavier devices. Weighing only 1.4kg, X-PLOR is 33% lighter and research suggests can provide 37% more oxygen per kg than leading competitors. X-PLOR is portable, increasing the mobility of people suffering from COPD and price efficient, costing less than tanks over the duration of the disease, and is upgradeable with user replaceable filters, so as the disease progresses, there is no need to buy another expensive higher capacity device, rather just change the filter as the prescription changes. Belluscura has exclusively licensed, acquired or filed 13 patents and applications in the field of concentrated oxygen generation and has a robust pipeline with additional oxygen enrichment products planned for release in 2020. Market Information Chronic obstructive pulmonary disease (COPD) is a progressive life-threatening lung disease. Over 250 million people worldwide suffer from COPD(2) . COPD is not curable, but patients with COPD are prescribed supplemental oxygen to help relieve shortness of breath and reduce the risk of death. According to the British Lung Foundation, in the U.K. an estimated 1.2 million people are living with diagnosed COPD.(3) Globally, the medical portable O(2) concentrator market is expected to grow from $1.4bn in 2018 to $2.4bn by 2024, with a CAGR of 9%.(4) Dr Clifford Gross, Chairman at Tekcapital commented, "We are delighted to see that Belluscura has strengthened its balance sheet and is on track to likely receive FDA clearance later this year. The fundraise was conducted at 15p per share, a 50% uplift over the valuation Tekcapital listed for Belluscura in its 2018 Annual Accounts. The Directors believe that Belluscura's new device will help to improve the quality of life and reduce treatment cost for individuals suffering from COPD." Tekcapital owns approximately 21.7% (9.3m shares) of Belluscura plc. About Belluscura plc Belluscura plc is an English company that is focused on improving healthcare and people's lives by developing new and innovative treatment platforms. They license and develop proprietary technologies that can be applied across a range of treatment possibilities. To learn more please visit About Tekcapital plc Tekcapital creates value from investing in new, university-developed intellectual properties and provides a range of IP investment services to make it easy for organisations to commercialise university-developed technology. Tekcapital is quoted on the AIM market of the London Stock Exchange (AIM: symbol TEK) and is headquartered in Oxford, in the UK. For more information, please visit
Tekcapital share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210227 11:14:50